Abstract

BackgroundPreliminary experience in laparoscopic liver surgery is usually suggested prior to implementation of a robotic liver resection program.MethodsThis was a retrospective cohort analysis of patients undergoing robotic (RLR) versus laparoscopic liver resection (LLR) for hepatocellular carcinoma at a center with concomitant initiation of robotic and laparoscopic programsResultsA total of 92 consecutive patients operated on between May 2014 and February 2019 were included: 40 RLR versus 52 LLR. Median age (69 vs. 67; p = 0.74), male sex (62.5% vs. 59.6%; p = 0.96), incidence of chronic liver disease (97.5% vs.98.1%; p = 0.85), median model for end-stage liver disease (MELD) score (8 vs. 9; p = 0.92), and median largest nodule size (22 vs. 24 mm) were similar between RLR and LLR. In the LLR group, there was a numerically higher incidence of nodules located in segment 4 (20.0% vs. 16.6%; p = 0.79); a numerically higher use of Pringle’s maneuver (32.7% vs. 20%; p = 0.23), and a shorter duration of surgery (median of 165.5 vs. 217.5 min; p = 0.04). Incidence of complications (25% vs.32.7%; p = 0.49), blood transfusions (2.5% vs.9.6%; p = 0.21), and median length of stay (6 vs. 5; p = 0.54) were similar between RLR and LLR. The overall (OS) and recurrence-free (RFS) survival rates at 1 and 5 years were 100 and 79 and 95 and 26% for RLR versus 96.2 and 76.9 and 84.6 and 26.9% for LLR (log-rank p = 0.65 for OS and 0.72 for RFS).ConclusionsBased on our results, concurrent implementation of a robotic and laparoscopic liver resection program appears feasible and safe, and is associated with similar oncologic long-term outcomes.

Highlights

  • Preliminary experience in laparoscopic liver surgery is usually suggested prior to implementation of a robotic liver resection program

  • The actuarial 1, 2, and 5-year OS and recurrence-free survival (RFS) were 100 and 79%; 95 and 62%; and 95 and 26.0% for RLR patients versus 96.2 and 76.9%; 86.5 and 61.5%; 84.6 and 26.9% for laparoscopic liver resection (LLR). (Fig. 1). With this retrospective cohort analysis, we aimed to evaluate the results of our initial experience with minimally invasive liver surgery (MILS) for hepatocellular carcinoma (HCC), whether it be in the form of RLR or LLR

  • Unlike the majority of robot-assisted surgery programs, which are usually implemented once solid experience with LLR has been achieved, our MILS program consisted of concomitant implementation of either technique

Read more

Summary

Introduction

Preliminary experience in laparoscopic liver surgery is usually suggested prior to implementation of a robotic liver resection program. Median age (69 vs 67; p = 0.74), male sex (62.5% vs 59.6%; p = 0.96), incidence of chronic liver disease (97.5% vs.98.1%; p = 0.85), median model for end-stage liver disease (MELD) score (8 vs 9; p = 0.92), and median largest nodule size (22 vs 24 mm) were similar between RLR and LLR. In the LLR group, there was a numerically higher incidence of nodules located in segment 4 (20.0% vs 16.6%; p = 0.79); a numerically higher use of Pringle’s maneuver (32.7% vs 20%; p = 0.23), and a shorter duration of surgery (median of 165.5 vs 217.5 min; p = 0.04). Conclusions Based on our results, concurrent implementation of a robotic and laparoscopic liver resection program appears feasible and safe, and is associated with similar oncologic long-term outcomes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call